For trauma surgeons and inpatient care teams, the goal of catheter management is often a race against the clock. The prevailing clinical wisdom has long been that the longer a urinary catheter remains in place, the higher the risk of infection. However, new data suggests that the act of removing and then reinserting a catheter may be far more dangerous than simply leaving it in place.
A retrospective study conducted at a New Jersey trauma center indicates that catheter reinsertion drives CAUTI (catheter-associated urinary tract infection) in patients with pelvic fractures, presenting a significant challenge to current protocols aimed at reducing “dwell time.” The findings suggest that the physical process of repeated catheterization creates a gateway for infection that outweighs the risks associated with prolonged use.
Catheter-associated urinary tract infections are a critical concern in hospital settings, accounting for approximately 9% of all healthcare-associated infections according to general public health data. These infections are not merely inconveniences; they are linked to increased patient morbidity, higher mortality rates, extended hospital stays, and the growing global crisis of antibiotic resistance.
The study focused on a specific and vulnerable population: adults with pelvic fractures who did not suffer urethral injuries. By analyzing patients treated between 2017 and 2024, researchers sought to understand why some patients developed infections despite efforts to remove catheters early through a process known as a “trial of void” (TOV).
The Paradox of the Trial of Void
A trial of void is a standard clinical assessment used to determine if a patient can urinate independently after their catheter is removed. The logic is straightforward: the sooner the catheter is out, the lower the risk of bacteria colonizing the urinary tract. When a TOV fails, clinicians must reinsert a Foley catheter to manage the patient’s urine output.
Even as the intent of an early TOV is to protect the patient, the study suggests that the failure of these trials can be counterproductive. Each time a catheter is reinserted, the urinary tract is exposed to periurethral flora—the bacteria naturally present on the skin and surrounding tissues. This process can disrupt existing biofilms and cause mucosal trauma, essentially “opening the door” for pathogens to enter the bladder.
The data reveals a stark correlation between the number of times a patient underwent catheter replacement and their likelihood of developing a CAUTI. For patients who never required a replacement, the infection rate was a negligible 2%. This rate rose slightly to 3.9% for those with one replacement, but spiked dramatically to 33.3% for those who required two replacements.
Risk Factors and Infection Rates
The most alarming findings emerged when researchers combined the number of reinsertions with the total duration of catheterization. While extended duration alone posed a relatively low risk, the combination of long-term use and repeated insertion created a high-risk environment.
| Catheter Status | Infection Rate (General) | Infection Rate (>7 Days Duration) |
|---|---|---|
| No Replacements | 2% | 4.9% |
| One Replacement | 3.9% | Not Specified |
| Two Replacements | 33.3% | 77.8% |
In patients whose catheterization exceeded seven days, those who underwent two replacements saw an infection rate of 77.8%. In contrast, patients in that same seven-day-plus duration group who did not undergo reinsertion had an infection rate of only 4.9%. This suggests that the mechanical trauma and bacterial introduction associated with reinsertion are the primary drivers of infection, rather than the mere passage of time.
Clinical Implications for Trauma Care
These findings challenge the “remove as early as possible” mantra if that removal is likely to be followed by a failed trial and subsequent reinsertion. For medical teams, the priority may need to shift from minimizing dwell time to maximizing the success rate of the first removal attempt.
The researchers suggest that optimizing the timing of TOVs—ensuring the patient is truly ready to void independently before attempting removal—could significantly lower infection rates. Strict adherence to aseptic insertion protocols remains paramount, as the “re-entry” phase is where the system is most vulnerable to contamination.
It is critical to note a significant limitation of this study: the cohort consisted exclusively of male patients. Because women have shorter urethras and different anatomical vulnerabilities, the researchers stated that these findings cannot be directly extrapolated to female patients. Further research is required to determine if the reinsertion risk is equally potent across all genders.
As a board-certified physician, I note that these results underscore the complexity of “best practices” in a hospital setting. What appears to be a proactive step—removing a device early—can inadvertently create a higher risk profile if the clinical circumstances do not support a successful transition to independent voiding.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should consult their healthcare provider for personalized medical guidance.
The medical community now looks toward prospective studies to determine the ideal “window” for TOVs in pelvic fracture patients to minimize the need for reinsertion. Future updates to trauma care guidelines may reflect a more nuanced approach to catheter dwell time, prioritizing stability over speed.
We invite healthcare professionals and patients to share their experiences with catheter management in the comments below. Please share this article to help spread awareness of these clinical findings.
